SCHEMBL6980294

SCHEMBL6980294

Sc1cnc(Cl)nc1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.52
ALDH1A1 P00352 4/20 0.52
LMNA P02545 3/20 0.52
HPGD P15428 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
GLA P06280 1/20 0.52
JUN P05412 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
PKM P14618 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.40
MAPT P10636 2/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
ADORA1 P30542 2/20 0.37
ADORA2A P29274 2/20 0.37
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30444276 0.80 KDM4E (0.55) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL25820968 0.80 KDM4E (0.55) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL2836957 0.78 KDM4E (0.53) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL15719941 0.77 ADORA1 (0.57) LMNAKMT2AADORA1ADORA2A
SCHEMBL3758203 0.77 KDM4E (0.52) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL27324019 0.77 MAPT (0.54) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL17111540 0.77 KDM4E (0.62) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL2348873 0.77 KDM4E (0.52) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL14422883 0.77 KDM4E (0.52) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL19347664 0.76 ADORA1 (0.54) KDM4EALDH1A1LMNAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862560-B1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 2003-04-02 EP disclosed
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 US disclosed